1Pasqualin A,Vollmer DG, Marron JA,et al. The effect of nicardipine on vasospasm in rabbit basilar artery after subarachnoid hemorrhage [ J ]. Neurosurgery, 1991,29:183-188.
2Longstreth WT, Nelson LM, Koepsell TD,et al. Clinical course of spontaneous subarachnoid hemorrhage:a population-based study in king county, washington[ J ]. Neurology, 1993,43:712-718.
3Lanzino G,Kassell NF, Germanson TP,et al. Age and outcome after aneurysmal subarachnoid hemorrhage:Why do older patients fare worse? [ J]. J Neurosurg, 1996,85:410-418.
6Findlay JM, Kassell NF, Weir BK,et al. A randomized trial of intraoperative intracisternal tissue plasminogen activator for the prevention of vasospasm [ J ]. Neurosurgery, 1995,37:168-176.
7Shibuya M,Suzuki Y,Enomoto H,et al. Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage [ J].Acta Neurochir Wien, 1994,131: i9-25.
4Horky LL, Pluta RM, Boock R J, et al. Role of ferrous iron chelator 2,2' -dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg, 1998, 88(2): 298-303.
5Pluta RM, Afshar JK, Thompson BG, et al. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage. J Neurosurg, 2000, 92 ( 1 ):121-126.
6Suzuki M, Asahara H, Endo S, et al. Increased levels of nitrite/nitrate in the cerebrospinal fluid of patients with subarachnoid hemorrhage.Neurosurg Rev, 1999, 22(2-3): 96-98.
7Sobey CG. Faraci FM. Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol, 1998, 25 ( 11 ): 867-876.
8Pluta RM, Boock R J, Afshar JK, et al. Source and cause of endothelin1 release into cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg, 1997, 87(2): 287-293.
9Zuccarello M, Boccaletti R, Romano A, et al. Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke, 1998, 29(9): 1924-1929.
10Kwan AL, Lin CL, Wu CS, et al. Delayed administration of the K+ channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Acta Neurochir (Wien), 2000, 142(2): 193-197.
